These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 7671094

  • 1. Clinical uses of insulin-like growth factor I.
    Hussain MA, Froesch ER.
    Adv Endocrinol Metab; 1995; 6():143-65. PubMed ID: 7671094
    [No Abstract] [Full Text] [Related]

  • 2. Insulin-like growth factor I: physiology, metabolic effects and clinical uses.
    Froesch ER, Hussain MA, Schmid C, Zapf J.
    Diabetes Metab Rev; 1996 Oct; 12(3):195-215. PubMed ID: 8959385
    [No Abstract] [Full Text] [Related]

  • 3. Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance.
    Ranke MB.
    Trends Endocrinol Metab; 2005 Oct; 16(4):190-7. PubMed ID: 15860416
    [Abstract] [Full Text] [Related]

  • 4. Experience with insulin-like growth factor I (IGF-I) treatment of growth hormone insensitivity syndrome (GHIS).
    Ranke MB, Wollmann HA, Savage MO.
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():259-66. PubMed ID: 10698590
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Diabetes mellitus and sports. Why the athletic diabetic patient uses less insulin].
    Neye H.
    Med Monatsschr Pharm; 1994 Sep; 17(9):273-6. PubMed ID: 7968779
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Insulin resistance: the clinical spectrum.
    Mantzoros CS, Flier JS.
    Adv Endocrinol Metab; 1995 Sep; 6():193-232. PubMed ID: 7671097
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recombinant human insulin-like growth factor I (rhIGF-I) and rhIGF-I/rhIGF-binding-protein-3: new growth treatment options?
    Rosenbloom AL.
    J Pediatr; 2007 Jan; 150(1):7-11. PubMed ID: 17188604
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
    Williams RM, Yuen K, White D, Mallard B, Dalton RN, Acerini CL, Dunger DB.
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
    [Abstract] [Full Text] [Related]

  • 18. How recombinant insulin analogs improve insulin therapy of diabetes mellitus: pathophysiology, clinical practice and recommendations.
    Tatoń J, Milicevic Z, Mozejko-Pastewka B, Bernas M, Czech A.
    Med Sci Monit; 2001 Oct; 7(4):848-59. PubMed ID: 11433220
    [Abstract] [Full Text] [Related]

  • 19. Insulin-like growth factor-I (lGF-l): safety and efficacy.
    Laron Z.
    Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():78-85. PubMed ID: 16456486
    [Abstract] [Full Text] [Related]

  • 20. Hepatic osteodystrophy in elderly: role of insulin-like growth factor-I and osteocalcin.
    Cotrozzi G, Giusti S, Bini S, Carloni V, Mazzocca A, Frati M.
    J Endocrinol Invest; 1999 Nov; 22(10 Suppl):88-9. PubMed ID: 10727064
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.